Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
German CML Study IIIA: Treatment Optimization in Chronic Myeloid Leukemia
NCT00025402Phase 3Unknown
- Sponsor
- III. Medizinische Klinik, Universitätsmedizin Mannheim
- Start
- Jul 1997
- Modality
- Cytokines & Interferons
- Countries
- 5
01
Overview
A Phase 3 trial of interferon alfa in chronic myeloid leukemia (CML), sponsored by III. Medizinische Klinik, Universitätsmedizin Mannheim. Status: unknown.
02
Drugs
interferon alfa
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT00025402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00025402.